-
Guangzhou Wondfo Biotech Partners with Indonesia’s Kimia Farma in IVD Field
•
China-based Guangzhou Wondfo Biotech Co., Ltd (SHE: 300482) has entered into a partnership with Indonesia’s state-owned pharmaceutical company, Kimia Farma (KAEF), in the in vitro diagnostics (IVD) field. The collaboration aims to strengthen the healthcare infrastructure in Indonesia, although no financial details have been disclosed. Background on Kimia Farma and…
-
Silk Round Fund and INA Invest in Indonesian Pharma Companies
•
The Chinese state-owned Silk Round Fund (SRF) and Indonesia’s sovereign fund INA have reportedly agreed to invest in two Indonesian pharmaceutical companies in a deal valued at around IDR 1.86 trillion (USD 120 million). The target companies are PT Kimia Farma Tbk (IDX: KAEF) and its subsidiary, PT Kimia Farma…
